ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in Phoenix, AZ

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Pancreatic Cancer
Colorectal Cancer
Stomach Cancer
Esophageal Cancer
Non-Small-Cell Lung Carcinoma

Adenocarcinoma trials near Phoenix, AZ, USA:

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates

The objective of this study is to estimate the R0 resection rate in patients with Resectable Pancreatic Ductal Adenocarcinoma (R-PDAC) as we...

Active, not recruiting
Pancreatic Adenocarcinoma
Pancreas Ductal Adenocarcinoma
Drug: Nab paclitaxel
Drug: Gemcitabine

Phase 2

Criterium

Scottsdale, Arizona, United States and 3 other locations

open-label study evaluating the efficacy and safety of nab-paclitaxel cisplatin, and gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma...

Active, not recruiting
Pancreatic Ductal Adenocarcinoma
Drug: nab-Paclitaxel + Cisplatin + Gemcitabine

Phase 2

HonorHealth Research Institute

Scottsdale, Arizona, United States and 3 other locations

(TPC) in participants with advanced/metastatic gastroesophageal adenocarcinoma. The primary hypothesis of this study is sacituzumab tirumote...

Enrolling
Gastroesophageal Cancer
Drug: Rescue medication
Drug: Supportive care measures

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Gilbert, Arizona, United States and 113 other locations

(nal-IRI), leucovorin, and fluorouracil (5-FU) for treatment of participants with histologically confirmed metastatic pancreatic ductal adenocarcinoma...

Active, not recruiting
Pancreatic Ductal Adenocarcinoma
Drug: Nanoliposomal irinotecan
Drug: Leucovorin

Phase 2

Cardiff Oncology

Phoenix, Arizona, United States and 5 other locations

and capecitabine monotherapy in patients with metastatic pancreatic adenocarcinoma whose disease has not progressed on a first line fluoropy...

Enrolling
Metastatic Pancreatic Adenocarcinoma
Drug: Capecitabine
Drug: Ivaltinostat

Phase 1, Phase 2

CG Pharmaceuticals

Scottsdale, Arizona, United States and 19 other locations

as First-Line or Second-Line Therapy in Adult Patients with Inoperable, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma...

Active, not recruiting
Gastric Adenocarcinoma
Gastric Cancer
Drug: Tislelizumab 200mg
Drug: DKN-01 400mg

Phase 2

Leap Therapeutics

Phoenix, Arizona, United States and 47 other locations

participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSignatur...

Enrolling
Endometrial Adenocarcinoma
Urothelial Carcinoma
Diagnostic Test: OncoSignature
Drug: ACR-368

Phase 1, Phase 2

Acrivon Therapeutics

Phoenix, Arizona, United States and 66 other locations

after complete surgical resection (R0) in participants with Stage I adenocarcinoma NSCLC who are ctDNA-positive, as determined by the Sponso...

Enrolling
Non-small Cell Lung Cancer
Drug: Pemetrexed
Drug: Rilvegostomig

Phase 3

AstraZeneca
AstraZeneca

Phoenix, Arizona, United States and 195 other locations

unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma. Why is this study being done? SPOTLIGHT is a new clinical st...

Active, not recruiting
Metastatic Gastric Adenocarcinoma or Cancer
Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer
Drug: fluorouracil
Drug: zolbetuximab

Phase 3

Astellas
Astellas

Phoenix, Arizona, United States and 219 other locations

The purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON...

Enrolling
Metastatic Pancreatic Ductal Adenocarcinoma
Pancreatic Ductal Adenocarcinoma
Drug: RMC-6236
Drug: nab-paclitaxel

Phase 1, Phase 2

Revolution Medicines
Revolution Medicines

Scottsdale, Arizona, United States and 16 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems